These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1893771)

  • 1. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity.
    Cutarelli PE; Lass JH; Lazarus HM; Putman SC; Jacobs MR
    Curr Eye Res; 1991 Jun; 10(6):557-63. PubMed ID: 1893771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of aminoglycosides and fluoroquinolones on keratocytes.
    Seitz B; Hayashi S; Wee WR; LaBree L; McDonnell PJ
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):656-65. PubMed ID: 8595966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro toxicity of lomefloxacin in rabbit corneal epithelial cell cultures.
    Portolés M; Igual A; Jauch A; Nos-Barbéra S
    Lens Eye Toxic Res; 1990; 7(3-4):469-80. PubMed ID: 2100173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR
    Am J Med; 1991 Dec; 91(6A):31S-34S. PubMed ID: 1662893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ
    Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
    Gorzynski EA; Gutman SI; Allen W
    Antimicrob Agents Chemother; 1989 Apr; 33(4):591-2. PubMed ID: 2524998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A; Hardardottir H; Bottolfsen KL
    Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
    Hardy DJ
    Am J Med; 1991 Dec; 91(6A):12S-14S. PubMed ID: 1662881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
    Soussy CJ; Deforges L; Le Van Thoi J; Duval J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro analysis of aminoglycoside corneal epithelial toxicity.
    Lass JH; Mack RJ; Imperia PS; Mallick K; Lazarus HM
    Curr Eye Res; 1989 Mar; 8(3):299-304. PubMed ID: 2707046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.
    Nakanishi N; Inoue M; Inoue K; Yamaguchi T; Mitsuhashi S
    Chemotherapy; 1990; 36(5):345-55. PubMed ID: 2209168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of temafloxacin for gram-positive pathogens.
    Bille J; Glauser MP
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():9-14. PubMed ID: 1664835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for gram-positive corneal pathogens.
    Cutarelli PE; Lazarus HM; Jacobs MR; Lass JH
    Curr Eye Res; 1993 Jul; 12(7):603-8. PubMed ID: 8222720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.